Indaptus Therapeutics Inc (INDP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 5,787 | 13,362 | 9,627 | 39,132 | 1,638 |
| Marketable Securities | N/A | N/A | 16,806 | N/A | N/A |
| Other current assets | 0 | 0 | 0 | 148 | 0 |
| TOTAL | $6,618 | $13,995 | $27,244 | $40,387 | $1,732 |
| Non-Current Assets | |||||
| PPE Net | N/A | 1 | 2 | 4 | 1 |
| Other Non-Current Assets | 720 | 928 | 818 | 186 | 45 |
| TOTAL | $720 | $929 | $820 | $189 | $46 |
| Total Assets | $7,339 | $14,924 | $28,064 | $40,577 | $1,778 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 3,310 | 2,672 | 3,353 | 4,508 | 598 |
| Other current liabilities | N/A | N/A | N/A | N/A | 1,417 |
| TOTAL | $3,394 | $2,774 | $3,433 | $4,604 | $2,016 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 0 | 73 | 0 | 73 | 0 |
| TOTAL | $N/A | $73 | $N/A | $73 | $N/A |
| Total Liabilities | $3,394 | $2,847 | $3,433 | $4,677 | $2,016 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 515 | 305 | 300 | 295 | 40 |
| Common Shares | 120 | 84 | 84 | 83 | 19 |
| Retained earnings | -60,439 | -45,417 | -29,994 | -15,671 | -7,960 |
| Other shareholders' equity | 0 | 0 | 97 | 0 | 0 |
| TOTAL | $3,945 | $12,077 | $24,631 | $35,900 | $-238 |
| Total Liabilities And Equity | $7,339 | $14,924 | $28,064 | $40,577 | $1,778 |